S&P Futures
5,875.75 -20.50 (-0.35%) Dow Futures
43,050.00 -127.00 (-0.29%) Nasdaq Futures
20,441.75 -77.75 (-0.38%) Russell 2000 Futures
2,246.00 -9.50 (-0.42%) Crude Oil
71.17 +0.61 (+0.86%) Gold
2,749.10 +10.20 (+0.37%)
MediPharm Labs Corp. (LABS.TO)
| Previous Close | 0.0750 |
| Open | 0.0750 |
| Bid | 0.0800 x N/A |
| Ask | 0.0850 x N/A |
| Day's Range | 0.0750 - 0.0800 |
| 52 Week Range | 0.0600 - 0.1000 |
| Volume | |
| Avg. Volume | 172,088 |
| Market Cap | 32.886M |
| Beta (5Y Monthly) | 0.88 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -0.0400 |
| Earnings Date | Nov 14, 2024 - Nov 24, 2024 |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | N/A |
CNW GroupMediPharm Labs Announces Departure of President and Co-Founder Keith Strachan
MediPharm Labs Corp. (TSX: LABS) (OTCQX: MEDIF) ("MediPharm", "MediPharm Labs" or the "Company"), a specialized, research-driven company focused on pharmaceutical-quality cannabis extraction and cannabis based health products, is announcing that President and Co-Founder Keith Strachan will be stepping down from his management position effective December 31, 2024. Keith will continue to provide strategic support and guidance to the Company by joining the Board of Directors effective January 1, 20
CNW GroupMediPharm Labs Announces $2.1M Debt Repayment
MediPharm Labs Corp. ("MediPharm" or the "Company") (TSX: LABS), a specialized, research-driven pharmaceutical company focused on cannabis-based health products, is pleased to announce that it has paid off the entire remaining convertible debt amount of $2.1 million, leaving the Company materially debt-free.
